Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
clinical trial data
Pharma
UCB shares results for Bimzelx's PsA triumph over Skyrizi
In a head-to-head psoriatic arthritis trial, UCB's Bimzelx achieved reduced disease activity in 49% of patients vs. 38% of those on AbbVie's Skyrizi.
Kevin Dunleavy
May 19, 2026 11:27am
Cytokinetics scores with Myqorzo in key cardiomyopathy trial
May 5, 2026 8:00am
Lilly's Ebglyss scores eczema trial win in children
Mar 16, 2026 10:50am
Neurocrine's Ingrezza misses in cerebral palsy trial
Dec 23, 2025 10:20am
Gilead's single-tablet HIV combo passes 2nd late-stage test
Dec 16, 2025 9:15am
Pfizer details Tukysa's 1st-line data in HER2 breast cancer
Dec 10, 2025 8:15am
